Table 2. Associated systemic and ocular conditions .

Etiology - systemic, patients, n (%) Spondyloarthropathies Behçet’s disease Undifferentiated connective tissue disorders JIA Sarcoidosis TINU Vogt-Koyanagi-Harada syndrome Multiple sclerosis	- 57 (12.8) 82 (18.5) 8 (1.8) 17 (3.8) 14 (3.1) 2 (0.4) 5 (1.1) 2 (0.4)
Etiology - ophthalmic, eyes, n (%) Herpetic uveitis Fuchs uveitic syndrome CMV uveitis Posner-Schlossmann syndrome Toxoplasmosis/toxocariasis	- 32 (5.3) 5 (0.8) 2 (0.3) 4 (0.7) 11 (1.8)
Uveitis treatment, eyes, n (%) Topical corticosteroids Systemic treatment Corticosteroids Conventional immunosuppressives Anti-TNFα agents Intravitreal dexamethasone implant Anterior Intermediate Posterior Panuveitis	- 594 (100) - 358 (60.3) 98 (16.4) 87 (14.5) 34 (5.7) 2 (0.3) 7 (1.2) 4 (0.7) 21 (3.5)

JIA: Juvenile idiopathic arthritis, TINU: Tubulointerstitial nephritis and uveitis syndrome, CMV: Cytomegalovirus, TNF: Tumor necrosis factor